Drug Type Gene therapy |
Synonyms RAG-1 program |
Target |
Mechanism RAG-1 stimulants(recombination activating 1 stimulants) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization- |
Active Organization |
Inactive Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Severe Combined Immunodeficiency | Preclinical | FR | 19 Oct 2021 |